Sargent Bickham Lagudis LLC Glaukos Corp Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Glaukos Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 100 shares of GKOS stock, worth $12,158. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$12,158
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$977 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$663 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$231 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$226 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$196 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.79B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...